Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Cough, cold and allergy (hay fever) remedies are set to post double-digit retail value growth in 2024, benefiting from the change in the exchange rate in Argentina. Argentina’s exchange rate appreciated in the first quarter of 2024, with an immediate…
The market for cough, cold, and allergy remedies in Slovakia is projected to maintain healthy growth in current value terms in 2024. While shortages of certain medicines and inflationary pressures of p[previous years will continue to have a lingering…
Cough, cold and allergy (hay fever) remedies is set to see current value growth in Norway in 2024. Cough, cold and allergy (hay fever) remedies is the largest OTC consumer health category in Norway, and, as such, struggled with rising maturity before…
Cough, cold and allergy (hay fever) remedies in Morocco is seeing generic variants gain ground in 2024. This is thanks to local consumers’ cost-consciousness, with affordability being a critical factor in purchasing decisions.
In 2024, cough, cold and allergy (hay fever) remedies remains stable, with no real changes in growth patterns. The overall category witnessed huge fluctuations during the COVID-19 era, and now things have settled back down again. The typical climate…
After the pandemic-driven spike in 2022, sales of cough, cold, and allergy (hay fever) remedies in Latvia are settling back to more normal patterns. As people return to their usual routines and adjust their purchasing habits demand for these OTC…
Cough, cold and allergy (hay fever) remedies is expected to see strong current value growth in Israel in 2024. The paediatric cough, cold and allergy (hay fever) remedies category is set to register good volume growth over 2024 as parents continue to…
Value sales of cough, cold and allergy (hay fever) remedies continue to rise in 2024, supported by both growing demand and further unit price increases. Products notably impacted by price rises include two of the largest value segments,…
The temperatures recorded since 2023 have been higher than the average. The Coastal El Niño begin at the end of 2022, with effect throughout 2023, while the Global Niño started in 2024, impacting the country.
The market for cough, cold, and allergy (hay fever) remedies in Nigeria is projected to see significant current value growth in 2024, continuing the momentum from 2023. This growth, however, is largely driven by rising prices due to high inflation…
Cough, cold and allergy (hay fever) remedies experienced retail value and volume growth in 2024 as consumers have fully returned to their pre-pandemic lifestyles and are more exposed to the elements, other people, and colds/coughs/flu. The rising…
Cough, cold, and allergy (hay fever) remedies is expected to be back on a normal growth track in Ireland in retail current value terms in 2024, after the disruption during and after the pandemic. While 2022 and 2023 saw big jumps in sales due to the…
Cough, cold and allergy (hay fever) remedies are expected to register moderate current value growth, though constant value growth will be more muted, as high costs continue to hit profit margins in spite of inflation easing. These products are…
In Estonia, the demand for cough, cold, and allergy remedies experiences a sharp increase during the colder months, with products like Coldrex and Sudafed seeing significant sales surges, often rising by 30-40% in winter. The market's performance is…
Cough, cold and allergy (hay fever) remedies is seeing robust sales in Egypt in 2024, at a higher value growth rate compared to 2023. Within this, we note that herbal and natural remedies remain popular, with ingredients like honey, ginger, and…
Sales of cough, cold and allergy remedies in Ecuador benefited greatly during the pandemic. After reaching such a high consumption base during 2020-2022, demand for these products has subsequently been in decline. However, sales remain higher than…
Cough, cold and allergy (hay fever) remedies in Costa Rica is poised to record robust growth in total current value sales in 2024, with overall demand remaining reasonably stable. Following the return to pre-pandemic routines and the abandonment of…
Cough, cold and allergy (hay fever) remedies is expected to maintain strong retail current value growth in South Korea in 2024. Nevertheless, while such products are commonly used for the symptoms of rhinitis, alternative methods of treatment are…
Cough, cold and allergy (hay fever) remedies has been one of the strongest categories in Portugal’s consumer health industry over 2024. The cold and flu seasons have led to more prolific symptoms in the post-pandemic era, as consumers had not been…
Cough, cold and allergy (hay fever) sales are falling slightly in Finland in 2024, having been in flux ever since the COVID-19 pandemic. However, different segments are facing different fortunes – sales of cough and cold products are suffering more…